Cullinan Oncology Ownership 2024 | Who Owns Cullinan Oncology Now?
Institutional Ownership
7.16%
Insider Ownership
4.51%
Retail Ownership
88.33%
Institutional Holders
34.00
Cullinan Oncology Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 17.78% | 20.73% | 7,648,268 | - | - | 133,385,794 | Jun 30, 2024 |
| BVF INC/IL | 13.37% | 2.81% | 5,750,683 | 2,553,982 | 79.89% | 100,291,912 | Jun 30, 2024 |
| BLACKROCK INC. | 8.25% | 0.00% | 3,550,207 | 1,121,214 | 46.16% | 61,915,609 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7.63% | 0.95% | 3,280,237 | 2,141,706 | 188.11% | 57,207,333 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.68% | 0.00% | 2,871,375 | 1,097,030 | 61.83% | 50,076,780 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 5.68% | 0.01% | 2,444,130 | -252,632 | -9.37% | 42,625,628 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.19% | 0.07% | 2,232,829 | 1,282,829 | 135.03% | 38,940,538 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 4.76% | 9.94% | 2,049,172 | -875,670 | -29.94% | 35,737,560 | Jun 30, 2024 |
| STATE STREET CORP | 4.51% | 0.00% | 1,941,188 | 515,729 | 36.18% | 33,854,319,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 4.02% | 0.01% | 1,728,545 | 1,695,345 | 5106.46% | 30,145,825 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 3.63% | 1.16% | 1,559,826 | 1,559,826 | 100.00% | 27,203,365 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.59% | 1.03% | 1,542,805 | 194,790 | 14.45% | 26,906,519 | Jun 30, 2024 |
| VR ADVISER, LLC | 3.21% | 1.53% | 1,379,965 | 1,379,965 | 100.00% | 24,066,590 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 3.06% | 0.10% | 1,316,005 | 1,316,005 | 100.00% | 22,951,127 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 2.84% | 3.58% | 1,221,145 | - | - | 21,296,769 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.75% | 0.03% | 1,184,037 | 1,136,993 | 2416.87% | 20,649,606 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.67% | 0.40% | 1,147,655 | 630,049 | 121.72% | 20,015,103 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.62% | 1.13% | 1,125,000 | 1,125,000 | 100.00% | 19,620,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.46% | 0.47% | 1,057,949 | 1,057,949 | 100.00% | 18,450,631 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 2.45% | 0.28% | 1,052,630 | 1,052,630 | 100.00% | 18,357,867 | Jun 30, 2024 |
Cullinan Oncology's largest institutional shareholder is BIOIMPACT CAPITAL LLC, holding 17.78% of the company's total share outstanding, currently valued at $133.39M. The top 10 institutional shareholders own together 77.88% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 17.78% | 20.73% | 7,648,268 | - | - | 133,385,794 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 4.76% | 9.94% | 2,049,172 | -875,670 | -29.94% | 35,737,560 | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT V, LLC | 1.53% | 7.33% | 657,905 | 657,905 | 100.00% | 11,473,863 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 2.84% | 3.58% | 1,221,145 | - | - | 21,296,769 | Jun 30, 2024 |
| BVF INC/IL | 13.37% | 2.81% | 5,750,683 | 2,553,982 | 79.89% | 100,291,912 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 0.88% | 2.38% | 377,323 | 377,323 | 100.00% | 6,580,513 | Jun 30, 2024 |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 1.38% | 1.66% | 595,489 | 595,489 | 100.00% | 10,385,328 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.14% | 1.64% | 921,138 | 350,000 | 61.28% | 16,064,647 | Jun 30, 2024 |
| VR ADVISER, LLC | 3.21% | 1.53% | 1,379,965 | 1,379,965 | 100.00% | 24,066,590 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 3.63% | 1.16% | 1,559,826 | 1,559,826 | 100.00% | 27,203,365 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.62% | 1.13% | 1,125,000 | 1,125,000 | 100.00% | 19,620,000 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.59% | 1.03% | 1,542,805 | 194,790 | 14.45% | 26,906,519 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7.63% | 0.95% | 3,280,237 | 2,141,706 | 188.11% | 57,207,333 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.53% | 0.60% | 657,895 | 657,895 | 100.00% | 11,473,689 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.61% | 0.53% | 263,817 | 5,229 | 2.02% | 4,600,968 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.46% | 0.47% | 1,057,949 | 1,057,949 | 100.00% | 18,450,631 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.67% | 0.40% | 1,147,655 | 630,049 | 121.72% | 20,015,103 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.79% | 0.37% | 341,262 | 341,262 | 100.00% | 5,951,609 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.53% | 0.35% | 658,338 | 658,338 | 100.00% | 11,481,415 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.05% | 0.32% | 20,000 | -5,114 | -20.36% | 348,800 | Jun 30, 2024 |
The largest Cullinan Oncology shareholder by % of total assets is BIOIMPACT CAPITAL LLC. The company owns 7.65M shares of Cullinan Oncology (CGEM), representing 20.73% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 13.37% | 2.81% | 5,750,683 | 2,553,982 | 79.89% | 100,291,912 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7.63% | 0.95% | 3,280,237 | 2,141,706 | 188.11% | 57,207,333 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 4.02% | 0.01% | 1,728,545 | 1,695,345 | 5106.46% | 30,145,825 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 3.63% | 1.16% | 1,559,826 | 1,559,826 | 100.00% | 27,203,365 | Jun 30, 2024 |
| VR ADVISER, LLC | 3.21% | 1.53% | 1,379,965 | 1,379,965 | 100.00% | 24,066,590 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 3.06% | 0.10% | 1,316,005 | 1,316,005 | 100.00% | 22,951,127 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.19% | 0.07% | 2,232,829 | 1,282,829 | 135.03% | 38,940,538 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.75% | 0.03% | 1,184,037 | 1,136,993 | 2416.87% | 20,649,606 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.62% | 1.13% | 1,125,000 | 1,125,000 | 100.00% | 19,620,000 | Jun 30, 2024 |
| BLACKROCK INC. | 8.25% | 0.00% | 3,550,207 | 1,121,214 | 46.16% | 61,915,609 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.68% | 0.00% | 2,871,375 | 1,097,030 | 61.83% | 50,076,780 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.46% | 0.47% | 1,057,949 | 1,057,949 | 100.00% | 18,450,631 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 2.45% | 0.28% | 1,052,630 | 1,052,630 | 100.00% | 18,357,867 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.74% | 0.31% | 749,916 | 749,916 | 100.00% | 13,078,535 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.53% | 0.35% | 658,338 | 658,338 | 100.00% | 11,481,415 | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT V, LLC | 1.53% | 7.33% | 657,905 | 657,905 | 100.00% | 11,473,863 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.53% | 0.60% | 657,895 | 657,895 | 100.00% | 11,473,689 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.67% | 0.40% | 1,147,655 | 630,049 | 121.72% | 20,015,103 | Jun 30, 2024 |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 1.38% | 1.66% | 595,489 | 595,489 | 100.00% | 10,385,328 | Jun 30, 2024 |
| STATE STREET CORP | 4.51% | 0.00% | 1,941,188 | 515,729 | 36.18% | 33,854,319,000 | Jun 30, 2024 |
As of Jun 30 2024, Cullinan Oncology's largest institutional buyer is BVF INC/IL. The company purchased 2.55M stocks of CGEM, valued at $100.29M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | 0.41% | 0.10% | 176,173 | -1,064,692 | -85.80% | 3,072,457 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 4.76% | 9.94% | 2,049,172 | -875,670 | -29.94% | 35,737,560 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -626,929 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 1.95% | 0.00% | 838,283 | -314,361 | -27.27% | 14,619,655 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 5.68% | 0.01% | 2,444,130 | -252,632 | -9.37% | 42,625,628 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.77% | 0.00% | 759,760 | -233,617 | -23.52% | 13,249,529 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -178,396 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -84,234 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -60,074 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -55,888 | -100.00% | - | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.09% | 0.02% | 39,884 | -39,796 | -49.94% | 696,000 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -36,401 | -100.00% | - | Jun 30, 2024 |
| MARTINGALE ASSET MANAGEMENT L P | 0.03% | 0.01% | 14,022 | -28,507 | -67.03% | 244,544 | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -21,250 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -20,225 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -16,347 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.94% | 0.00% | 403,878 | -16,339 | -3.89% | 7,043,633 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 1,721 | -15,548 | -90.03% | 29,412 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,742 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Cullinan Oncology's biggest institutional seller is BRAIDWELL LP. The company sold -1.06M shares of CGEM, valued at $3.07M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | 3.63% | 1.16% | 1,559,826 | 1,559,826 | 100.00% | 27,203,365 | Jun 30, 2024 |
| VR ADVISER, LLC | 3.21% | 1.53% | 1,379,965 | 1,379,965 | 100.00% | 24,066,590 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 3.06% | 0.10% | 1,316,005 | 1,316,005 | 100.00% | 22,951,127 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.62% | 1.13% | 1,125,000 | 1,125,000 | 100.00% | 19,620,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.46% | 0.47% | 1,057,949 | 1,057,949 | 100.00% | 18,450,631 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 2.45% | 0.28% | 1,052,630 | 1,052,630 | 100.00% | 18,357,867 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.74% | 0.31% | 749,916 | 749,916 | 100.00% | 13,078,535 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.53% | 0.35% | 658,338 | 658,338 | 100.00% | 11,481,415 | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT V, LLC | 1.53% | 7.33% | 657,905 | 657,905 | 100.00% | 11,473,863 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.53% | 0.60% | 657,895 | 657,895 | 100.00% | 11,473,689 | Jun 30, 2024 |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 1.38% | 1.66% | 595,489 | 595,489 | 100.00% | 10,385,328 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 0.88% | 2.38% | 377,323 | 377,323 | 100.00% | 6,580,513 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.79% | 0.37% | 341,262 | 341,262 | 100.00% | 5,951,609 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.38% | 0.01% | 163,047 | 163,047 | 100.00% | 2,843,540 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.35% | 0.00% | 150,708 | 150,708 | 100.00% | 2,628,348 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.35% | 0.00% | 148,773 | 148,773 | 100.00% | 2,594,601 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.27% | 0.00% | 114,195 | 114,195 | 100.00% | 1,991,561 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.23% | 0.01% | 98,296 | 98,296 | 100.00% | 1,714,282 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.22% | 0.00% | 92,869 | 92,869 | 100.00% | 1,619,635 | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | 0.17% | 0.07% | 74,827 | 74,827 | 100.00% | 1,304,983 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.16% | 0.00% | 68,534 | 68,534 | 100.00% | 1,195,233 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.12% | 0.18% | 53,261 | 53,261 | 100.00% | 928,872 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.06% | 0.08% | 25,976 | 25,976 | 100.00% | 453,021 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 20,796 | 20,796 | 100.00% | 362,682 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 18,528 | 18,528 | 100.00% | 322,665 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.04% | 0.02% | 18,026 | 18,026 | 100.00% | 314,373 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 16,956 | 16,956 | 100.00% | 294,334 | Jun 30, 2024 |
| MARINER, LLC | 0.04% | 0.00% | 16,354 | 16,354 | 100.00% | 285,214 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.03% | 0.04% | 12,164 | 12,164 | 100.00% | 212,140 | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.02% | 0.00% | 10,460 | 10,460 | 100.00% | 182,422 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 0.01% | 0.00% | 2,847 | 2,847 | 100.00% | 49,652 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 50 | 50 | 100.00% | 872 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 25 | 25 | 100.00% | 436 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | - | 7 | 7 | 100.00% | 123 | Jun 30, 2024 |
Cullinan Oncology's largest new institutional shareholder by number of shares is AVIDITY PARTNERS MANAGEMENT LP, purchased 1.56M shares, valued at $27.20M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOGOS GLOBAL MANAGEMENT LP | - | - | - | -700,000 | -100.00% | - | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -626,929 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -178,396 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -84,234 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -60,074 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -55,888 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -36,401 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -21,250 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -20,225 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -16,347 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,742 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,286 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -1,273 | -100.00% | - | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | - | - | - | -723 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -119 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
Cullinan Oncology's largest sold out institutional shareholder by shares sold is LOGOS GLOBAL MANAGEMENT LP, sold -0.70M shares, valued at -, as of undefined.
Cullinan Oncology Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Tema ETF Trust | 0.36% | 16,147 | 241 | 1.52% | Feb 29, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.19% | 1,582,720 | 147,100 | 10.25% | Jan 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.11% | 8,053 | 8,053 | - | Sep 30, 2022 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 351,360 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 465,700 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 14,892 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.02% | 249,784 | - | - | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 31,561 | -2,463 | -7.24% | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,070,200 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 95,771 | 2,896 | 3.12% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 41,579 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 9,643 | 1,239 | 14.74% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,629 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 146,569 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 28,026 | 4,484 | 19.05% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,463,888 | -644,103 | -30.56% | Mar 31, 2024 |
| Harbor ETF Trust | 0.00% | 14,463 | 4,140 | 40.10% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 660 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 28,826 | - | - | Feb 29, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 42,300 | 8,400 | 24.78% | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.00% | 129,532 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 80,688 | 13,510 | 20.11% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 337,679 | 26,815 | 8.63% | Feb 29, 2024 |
| Cambria ETF Trust | 0.00% | 12,760 | 12,760 | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 193,200 | - | - | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.00% | 20,000 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,599 | 615 | 31.00% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 27,770 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 53,500 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 16,561 | 2,653 | 19.08% | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 17,051 | 278 | 1.66% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 3,044 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 13,407 | 2,320 | 20.93% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 290,483 | 19,132 | 7.05% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,074 | -1,449 | -7.82% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 4,500 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 554,138 | 76,891 | 16.11% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,456 | -990 | -13.30% | Mar 31, 2024 |
| ProFunds | 0.00% | 5,128 | 4,910 | 2252.29% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 44,937 | 10,085 | 28.94% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 60,157 | - | - | Jan 31, 2024 |
| Managed Portfolio Series | 0.00% | 8,053 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 1,500 | - | - | Mar 28, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 1,440,145 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 10,634 | -166 | -1.54% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 79,821 | 19,964 | 33.35% | Feb 29, 2024 |
| Global X Funds | 0.00% | 13,067 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 170,864 | 5,872 | 3.56% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 8,797 | -1,264 | -12.56% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,139 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 11,305 | - | - | Feb 29, 2024 |
| Trust for Advised Portfolios | 0.00% | 3,337 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,932 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 427 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 22,083 | -1,306 | -5.58% | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,500 | 1,200 | 16.44% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 10,834 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 11,750 | 7,826 | 199.44% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 1,190,168 | -32,973 | -2.70% | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,139 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 76,872 | -10,378 | -11.89% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 113,501 | 19,849 | 21.19% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 217 | - | - | Dec 31, 2023 |
| RBC FUNDS TRUST | 0.00% | 4,900 | - | - | Mar 28, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,020 | - | - | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 3,244 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 9,923 | 751 | 8.19% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,714 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,849 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 8,649 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,985 | 1,187 | 20.47% | Feb 29, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 97,037 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 108 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 154 | - | - | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 808,540 | 193,224 | 31.40% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 600 | - | - | Mar 28, 2024 |
| SEASONS SERIES TRUST | 0.00% | 493 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 53,815 | - | - | Jan 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 5,393 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 1,900 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 7,304 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,635 | 677 | 22.89% | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 35,632 | 11,963 | 50.54% | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 170 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 14 | - | - | Dec 31, 2023 |
| PGIM ETF TRUST | 0.00% | 748 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 2,237 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 7,747 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 871 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,929 | 221 | 8.16% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 436 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 7,345 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 10,723 | 90 | 0.85% | Mar 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 2,124 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 19,064 | -539 | -2.75% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,149 | 398 | 53.00% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 1,353 | - | - | Feb 29, 2024 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 147 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 9,439 | -3,363 | -26.27% | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 10,855 | 1,159 | 11.95% | Mar 31, 2024 |
Cullinan Oncology's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 16.15K shares, compromising 0.36% of its total assets.
Cullinan Oncology Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 34 | -70.43% |
| 31 Mar, 24 | 115 | 1.77% |
| 31 Dec, 23 | 113 | 6.60% |
| 30 Sep, 23 | 106 | -0.93% |
| 30 Jun, 23 | 107 | 4.90% |
| 31 Mar, 23 | 102 | 5.15% |
| 31 Dec, 22 | 97 | - |
| 30 Sep, 22 | 97 | 14.12% |
| 30 Jun, 22 | 85 | 6.25% |
| 31 Mar, 22 | 80 | 6.67% |
| 31 Dec, 21 | 75 | 13.64% |
| 30 Sep, 21 | 66 | -7.04% |
| 30 Jun, 21 | 71 | 1.43% |
| 31 Mar, 21 | 70 | - |
As of 30 Jun 24, 34 institutions are holding Cullinan Oncology's shares, representing a decrease of -70.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,077,679 | -92.18% |
| 31 Mar, 24 | 39,373,046 | 6.88% |
| 31 Dec, 23 | 36,838,443 | -3.03% |
| 30 Sep, 23 | 37,989,760 | 3.06% |
| 30 Jun, 23 | 36,860,088 | 14.24% |
| 31 Mar, 23 | 32,264,765 | -14.42% |
| 31 Dec, 22 | 37,699,468 | 1.83% |
| 30 Sep, 22 | 37,020,289 | -1.47% |
| 30 Jun, 22 | 37,571,507 | 1.90% |
| 31 Mar, 22 | 36,871,516 | 1.33% |
| 31 Dec, 21 | 36,387,604 | 7.37% |
| 30 Sep, 21 | 33,889,466 | 5.08% |
| 30 Jun, 21 | 32,250,734 | 2.96% |
| 31 Mar, 21 | 31,323,171 | - |
Cullinan Oncology (CGEM) has 3.08M shares outstanding as of 30 Jun 24, down -92.18% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 7.16% | 0.08% |
| 31 Mar, 24 | 92.01% | 1.24% |
| 31 Dec, 23 | 86.20% | 0.95% |
| 30 Sep, 23 | 95.09% | 1.16% |
| 30 Jun, 23 | 90.61% | 1.44% |
| 31 Mar, 23 | 79.31% | 1.14% |
| 31 Dec, 22 | 83.47% | 1.27% |
| 30 Sep, 22 | 81.17% | 1.16% |
| 30 Jun, 22 | 83.73% | 1.22% |
| 31 Mar, 22 | 82.98% | 1.16% |
| 31 Dec, 21 | 84.47% | 1.39% |
| 30 Sep, 21 | 78.02% | 1.41% |
| 30 Jun, 21 | 74.49% | 1.34% |
| 31 Mar, 21 | 74.62% | - |
As of 30 Jun 24, Cullinan Oncology is held by 7.16% institutional shareholders, representing a 0.08% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 20 | -67.21% |
| 31 Mar, 24 | 61 | -11.59% |
| 31 Dec, 23 | 69 | 50.00% |
| 30 Sep, 23 | 46 | -11.54% |
| 30 Jun, 23 | 52 | 8.33% |
| 31 Mar, 23 | 48 | -11.11% |
| 31 Dec, 22 | 54 | -5.26% |
| 30 Sep, 22 | 57 | 26.67% |
| 30 Jun, 22 | 45 | 40.63% |
| 31 Mar, 22 | 32 | -31.91% |
| 31 Dec, 21 | 47 | 17.50% |
| 30 Sep, 21 | 40 | - |
| 30 Jun, 21 | 40 | -42.86% |
| 31 Mar, 21 | 70 | - |
20 institutional shareholders have increased their position in CGEM stock as of 30 Jun 24 compared to 61 in the previous quarter (a -67.21% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -75.00% |
| 31 Mar, 24 | 36 | 56.52% |
| 31 Dec, 23 | 23 | -25.81% |
| 30 Sep, 23 | 31 | -18.42% |
| 30 Jun, 23 | 38 | 15.15% |
| 31 Mar, 23 | 33 | 50.00% |
| 31 Dec, 22 | 22 | -15.38% |
| 30 Sep, 22 | 26 | 13.04% |
| 30 Jun, 22 | 23 | -23.33% |
| 31 Mar, 22 | 30 | 87.50% |
| 31 Dec, 21 | 16 | 45.45% |
| 30 Sep, 21 | 11 | -42.11% |
| 30 Jun, 21 | 19 | - |
| 31 Mar, 21 | - | - |
9 institutional shareholders have reduced their position in CGEM stock as of 30 Jun 24 compared to 36 in the previous quarter (a -75.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 34 | -70.43% | 3,077,679 | -92.18% | 7.16% | 0.08% | 20 | -67.21% | 9 | -75.00% |
| 31 Mar, 24 | 115 | 1.77% | 39,373,046 | 6.88% | 92.01% | 1.24% | 61 | -11.59% | 36 | 56.52% |
| 31 Dec, 23 | 113 | 6.60% | 36,838,443 | -3.03% | 86.20% | 0.95% | 69 | 50.00% | 23 | -25.81% |
| 30 Sep, 23 | 106 | -0.93% | 37,989,760 | 3.06% | 95.09% | 1.16% | 46 | -11.54% | 31 | -18.42% |
| 30 Jun, 23 | 107 | 4.90% | 36,860,088 | 14.24% | 90.61% | 1.44% | 52 | 8.33% | 38 | 15.15% |
| 31 Mar, 23 | 102 | 5.15% | 32,264,765 | -14.42% | 79.31% | 1.14% | 48 | -11.11% | 33 | 50.00% |
| 31 Dec, 22 | 97 | - | 37,699,468 | 1.83% | 83.47% | 1.27% | 54 | -5.26% | 22 | -15.38% |
| 30 Sep, 22 | 97 | 14.12% | 37,020,289 | -1.47% | 81.17% | 1.16% | 57 | 26.67% | 26 | 13.04% |
| 30 Jun, 22 | 85 | 6.25% | 37,571,507 | 1.90% | 83.73% | 1.22% | 45 | 40.63% | 23 | -23.33% |
| 31 Mar, 22 | 80 | 6.67% | 36,871,516 | 1.33% | 82.98% | 1.16% | 32 | -31.91% | 30 | 87.50% |
| 31 Dec, 21 | 75 | 13.64% | 36,387,604 | 7.37% | 84.47% | 1.39% | 47 | 17.50% | 16 | 45.45% |
| 30 Sep, 21 | 66 | -7.04% | 33,889,466 | 5.08% | 78.02% | 1.41% | 40 | - | 11 | -42.11% |
| 30 Jun, 21 | 71 | 1.43% | 32,250,734 | 2.96% | 74.49% | 1.34% | 40 | -42.86% | 19 | - |
| 31 Mar, 21 | 70 | - | 31,323,171 | - | 74.62% | - | 70 | - | - | - |
Cullinan Oncology Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cullinan Oncology's stock was made by Michaelson Jennifer on Jul 09 2024, selling 8,000 shares at $16.33 per share (valued at $130.64K).
Cullinan Oncology Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 1 | 200.00% |
| Q2 2024 | 11 | 8 | 137.50% |
| Q1 2024 | 16 | 16 | 100.00% |
| Q4 2023 | - | 11 | - |
| Q2 2023 | 7 | 25 | 28.00% |
| Q1 2023 | 17 | 8 | 212.50% |
| Q4 2022 | 3 | 2 | 150.00% |
| Q3 2022 | 2 | 9 | 22.22% |
| Q2 2022 | 16 | 12 | 133.33% |
| Q1 2022 | 15 | 1 | 1500.00% |
| Q4 2021 | 3 | 12 | 25.00% |
| Q3 2021 | 11 | 87 | 12.64% |
| Q1 2021 | 37 | 41 | 90.24% |
2 total buy trades, and 1 total sell trades (buy/sell ratio of 2.00%) were made by Cullinan Oncology's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | 11 | - |
| Q2 2023 | - | 23 | - |
| Q1 2023 | - | 5 | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 8 | - |
| Q2 2022 | 4 | 9 | 44.44% |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 6 | - |
| Q3 2021 | - | 81 | - |
| Q1 2021 | 6 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Cullinan Oncology's stocks.
Cullinan Oncology Peer Ownership
| Ticker | Company |
|---|---|
| OLMA | Olema Pharmaceuticals, Inc. |
| SANA | Sana Biotechnology, Inc. |
| TALS | Tourmaline Bio, Inc. |
| ZNTL | Zentalis Pharmaceuticals, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| VOR | Vor Biopharma Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| AUTL | Autolus Therapeutics plc |
| ACET | Adicet Bio, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| LIFE | aTyr Pharma, Inc. |
CGEM Ownership FAQ
Who Owns Cullinan Oncology?
Cullinan Oncology is owned by institutional shareholders (7.16%), insiders (4.51%), and public (88.33%). The largest institutional shareholder of Cullinan Oncology is BIOIMPACT CAPITAL LLC (17.78% of total shares) and the top mutual fund owner is Tema ETF Trust (0.36% of total shares).
Who are the major institutional shareholders of Cullinan Oncology?
Cullinan Oncology's major institutional shareholders are BIOIMPACT CAPITAL LLC, BVF INC/IL, BLACKROCK INC., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and VANGUARD GROUP INC. The top five shareholders own together 53.71% of the company's share outstanding.
How many Cullinan Oncology shareholders are there?
As of Jun 2024, there are 34 institutional shareholders of Cullinan Oncology.
What percentage of Cullinan Oncology is owned by BIOIMPACT CAPITAL LLC?
BIOIMPACT CAPITAL LLC owns 7.65M shares of Cullinan Oncology, representing 17.78% of the company's total shares outstanding, valued at $133.39M (as of Jun 2024).
What percentage of Cullinan Oncology is owned by BVF INC/IL?
As of Jun 2024, BVF INC/IL holds 5.75M shares of Cullinan Oncology (CGEM), compromising 13.37% of the company, valued at $100.29M.
What percentage of Cullinan Oncology is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Cullinan Oncology. The company owns 3.55M of the company's shares outstanding (worth $61.92M).